MicroRNA alterations in head and neck squamous cell carcinoma.
MicroRNAs (mirs) are small noncoding RNA molecules (~22 nucleotides) that regulate posttranscriptional gene expression. Currently, there has not been a comprehensive study of their role in primary head and neck squamous cell carcinoma (HNSCC). To determine the role of mirs in HNSCC, we screened for altered microRNA expression in HNSCC primary tissue and cell lines. We then further tested the functional impact of alterations of specific mirs. An initial screening of 4 primary HNSCC, 4 normal mucosal controls and 4 HNSCC cell lines was analyzed for mature microRNA expression by microarray. Significance was determined using significance analysis of microarrays (SAM). Nine microRNAs were found by SAM to be upregulated or downregulated in tumor tissue including mir-21, let-7, 18, 29c, 142-3p, 155, 146b (overexpressed) and 494 (underexpressed). Mir-21 was validated by qRT-PCR. Functional validation by growth assays was performed, further validating mir-21. Transfection of mir-21 into JHU-011 and JHU-012 cell lines showed a 39% increase in cell growth at 72 hr relative to controls (p < 0.05). Transfection of the inhibitor into JHU-O12 cell lines showed a 92% decrease in cell growth relative to controls at 72 hr (p < 0.05). In addition, flow cytometry analysis of JHU-012 cells 48 hr after mir-21 inhibitor transfection showed a statistically significant increase in cytochrome c release and increased apoptosis. These differentially expressed microRNAs may be of interest as potential novel oncogenes and tumor suppressor genes in HNSCC. Mir-21 is a putative oncogenic microRNA in head and neck cancer.
Chang
Steven S
SS
Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287-0910, USA.
Jiang
Wei Wen
WW
Smith
Ian
I
Poeta
Luana M
LM
Begum
Shahnaz
S
Glazer
Chad
C
Shan
Shannon
S
Westra
William
W
Sidransky
David
D
Califano
Joseph A
JA
D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000235:genetics*; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000378:metabolism; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D045304:Cytochromes c / Q000378:metabolism; D015536:Down-Regulation; D005434:Flow Cytometry; D015972:Gene Expression Regulation, Neoplastic; D006258:Head and Neck Neoplasms / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D035683:MicroRNAs / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D015203:Reproducibility of Results; D020133:Reverse Transcriptase Polymerase Chain Reaction; D044767:Ubiquitin-Protein Ligases / Q000235:genetics*; D015854:Up-Regulation
D014408:Biomarkers, Tumor; C524940:MIRN21 microRNA, human; D035683:MicroRNAs; D045304:Cytochromes c; C403126:MYLIP protein, human; D044767:Ubiquitin-Protein Ligases
Clin Cancer Res. 1997 Apr;3(4):501-5
9815712
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11755-60
15284443
Cancer Res. 2006 Jun 15;66(12):6097-104
16778182
Blood. 2007 Aug 15;110(4):1330-3
17496199
Circ Res. 2007 Jun 8;100(11):1579-88
17478730
Cancer Res. 2007 Sep 15;67(18):8699-707
17875710
PLoS One. 2007 Oct 10;2(10):e1020
17925868
Cell. 1993 Dec 3;75(5):843-54
8252621
Cell. 2005 Jul 15;122(1):6-7
16009126
Gastroenterology. 2007 Aug;133(2):647-58
17681183
Cell. 2005 Jan 14;120(1):15-20
15652477
Blood. 2007 Jun 1;109(11):4944-51
17327404
J Cell Biochem. 2006 Oct 15;99(3):671-8
16924677
J Clin Oncol. 2006 Oct 10;24(29):4677-84
16966691
Nat Rev Cancer. 2006 Nov;6(11):857-66
17060945
Genes Chromosomes Cancer. 2007 Apr;46(4):336-47
17243163
Cancer Res. 2005 Aug 15;65(16):7065-70
16103053
Int J Cancer. 2005 May 1;114(5):806-16
15609302
Oncogene. 2007 Apr 26;26(19):2799-803
17072344
CA Cancer J Clin. 2002 Jan-Feb;52(1):23-47
11814064
Cancer Res. 2007 Jul 1;67(13):6031-43
17616659
Int J Cancer. 2007 Sep 1;121(5):1156-61
17487835
Int J Cancer. 2007 Mar 1;120(5):1046-54
17149698
J Biol Chem. 2007 May 11;282(19):14328-36
17363372
Cancer Res. 2005 Jul 15;65(14):6029-33
16024602
Am J Pathol. 2007 Jun;170(6):1831-40
17525252
Cell Microbiol. 2007 Dec;9(12):2784-94
17944962
Pharmacol Res. 2007 Sep;56(3):248-53
17702597